Frequent methylation of CALCA has been reported in hematological cancers, especially in myelodysplastic syndromes [21] and in acute leukemia, in which it was associated with a higher risk of relapse and poor clinical outcome [22, 23]. The gene discussed is CALCA; the disease is hematopoietic and lymphoid cell neoplasm.